Long-Term and Short-Term Antidepressant Use in General Practice: Data from a Large Cohort in the Netherlands

Psychotherapy and Psychosomatics

Volumn 86, Issue 6, 2017, Pages 362-369

  Huijbregts, Klaas M ^a,c   Hoogendoorn, Adriaan W ^a   Slottje, Paulien ^b   Van Balkom, Anton J L M ^a   Batelaan, Neeltje M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GGNet   (Netherlands)

Author keywords

Antidepressant medication; Anxiety; Depressive disorder; Disease management; Long term caer

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; PRESCRIPTION DRUG;

ADULT; AGE; ANXIETY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FEMALE; GENERAL PRACTICE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; ANXIETY DISORDER; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COHORT STUDIES; DEPRESSIVE DISORDER; GENERAL PRACTICE; HUMANS; LONG-TERM CARE; NETHERLANDS; PRESCRIPTION DRUGS;

EID: 85033377834     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000480456     Document Type: Article

References (32)

1. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, et al: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007; 8: 67-104.
2. Cleare A, Pariante C, Young A, Anderson I, Christmas D, Cowen P, et al: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol (Oxf) 2015; 29: 459-525.
3. National Institute for Health and Clinical Excellence: Depression in Adults: Recognition and Management [Internet]. 2009. http://www.nice.org.uk/guidance/cg90 (accessed Jan 4, 2016).
4. Piek E, van der Meer K, Nolen WA: Guideline recommendations for long-term treatment of depression with antidepressants in primary care - a critical review. Eur J Gen Pract 2010; 16: 106-112.
5. Bandelow B, Zohar J, Hollander E, Kasper S, Möller H-J, Kasper S: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - first revision. World J Biol Psychiatry 2008; 9: 248-312.
6. GIP/College voor Zorgverzekeringen: Aantal Gebruikers 2006-2010 voor ATC-Subgroep N06: Psychoanaleptica Raming voor de Totale Zvw-Populatie. 2016. www.gipdatabank. nl (accessed October 26, 2016).
7. De Graaf R, Ten Have M, Van Gool C, Van Dorsselaer S: Prevalentie van psychische aandoeningen en trends van 1996 to 2009: resultaten van NEMESIS-2. Tijdschr Psychiatr 2012; 54: 27-38.
8. Noordam R, Aarts N, Verhamme KM, Sturkenboom MC, Stricker BH, Visser LE: Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study. Eur J Clin Pharmacol 2015; 71: 369-375.
9. Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009; 66: 848-856.
10. Moore M, Yueng HM, Dunn N, Mullee MA, Maskell J, Kendrick T: Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 2009; 339:b3999.
11. Vektis: TherapietrouwMonitor. 2015. http://www.therapietrouwmonitor.nl/cijfers/depressie-0 (accessed Sep 9, 2015).
12. Mojtabai R, Olfson M: National trends in long-term use of antidepressant medications: results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry 2014; 75: 169-177.
13. Bosman RC, Huijbregts KM, Verhaak PF, Ruhé HG, Van Marwijk HW, van Balkom AJ, Batelaan NM: Long-term antidepressant use: a qualitative study on perspectives of patients and GPs. Br J Gen Pract 2016; 66:e708-e719.
14. Batelaan NM, Bosman RC, Muntingh A, Scholten W, Huijbregts KM; van Balkom AJLM: Is it wise to discontinue antidepressants in anxiety disorders? A meta-analysis of relapse prevention trials. BMJ 2017;358:j3927.
15. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-661.
16. Leydon GM, Rodgers L, Kendrick T: A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract 2007; 24: 570-575.
17. Fava GA: Rational use of antidepressant drugs. Psychother Psychosom 2014; 83: 197-204.
18. Ashton AK, Jamerson BD, L Weinstein W, Wagoner C: Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey. Curr Ther Res Clin Exp 2005; 66: 96-106.
19. Cohen A, Gilman SE, Houck PR, Szanto K, Reynolds CF 3rd: Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 272-277.
20. Cloos J, Bocquet V, Rolland-Portal I, Koch P, Chouinard G: Hypnotics and triazolobenzodiazepines - best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry. Psychother Psychosom 2015; 84: 273-283.
21. Netherlands College of General Practitioners (NHG): NHG standaard Angst. 2012. https://www.nhg.org/standaarden/volledig/nhgstandaard-angst#idm114768 (accessed Jan 21, 2014).
22. Netherlands College of General Practitioners (NHG): Standaard Depressie. 2012. https://www.nhg.org/standaarden/samenvatting/depressie#idp42371872 (accessed April 5, 2014).
23. De Waal MW, Arnold IA, Eekhof JA, Van Hemert AM: Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004; 184: 470-476.
24. Bentzen N (ed): WONCA international glossary for general/family practice. Fam Pract 1995; 12: 267.
25. Johnson CF, Macdonald HJ, Atkinson P, Buchanan AI, Downes N, Dougall N: Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study. Br J Gen Pract 2012; 62: 773-779.
26. Vektis; Instituut voor Verantwoord Medicjngebruik: Volume long-term users of antidepressant medication. https://www.volksgezondheidenzorg.info/onderwerp/eerstelijnszorg/regionaal-internationaal/huisartsenzorg#node-voorschrijfgedragtherapiekeuze-tweepositiepostcodegebied (accessed February 14, 2017).
27. Fava GA, Gatti A, Belaise C, Guidi J, Offidani E: Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84: 72-81.
28. Netherlands College of General Practitioners (NHG): NHG Standaard Pijn. 2016. https://www.nhg.org/standaarden/volledig/nhgstandaard-pijn (accessed Aug 16, 2016).
29. Chouinard G, Chouinard VA: New classification of selective serotonin reuptake inhibitor withdrawal. Psychother Psychosom 2015; 84: 63-71.
30. Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA: The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 2016; 85: 270-288.
31. Gardarsdottir H, Egberts TC, Stolker JJ, Heerdink ER: Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias. Am J Epidemiol 2009; 170: 280-285.
32. Cosci F, Guidi J, Balon R, Fava GA: Clinical methodology matters in epidemiology: not all benzodiazepines are the same. Psychother Psychosom 2015; 84: 262-264.